Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Jesse Ledger, Chief Executive Officer, Nuvo Pharmaceuticals Inc.
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Nuvo Pharmaceuticals Inc.
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
Inside the Mind of a Tennis Pro: Rituals, Signature Moves, and 2017 Goals
00:10:00
Brett Harriss, analyst and associate portfolio manager at G Research, discusses hesitancy in investing in streaming on "Power Lunch."
00:00:00
Visioneering Technologies' growth strategies to tackle COVID-19 - Dr Stephen Snowdy, CEO, Visioneering Technologies Inc
00:10:00
Wallenstam AB Celebrates 75 Years with Record Q3 Performance and Exciting Future Plans | Hans Wallenstam, CEO, Wallenstam AB.
00:10:00
Exploring Planetel's Growth Strategy and Market Performance: Insights on Organic Expansion, Acquisitions, and Government Investments | President Bruno Pianetti, PLANETEL S.P.A.
00:10:00
Works with young founders solving high-impact problems|Alex Fiance,Co-Founder & Co-CEO,Kairos HQ
00:10:00
Arcadia Minerals: Leading Namibian Lithium Exploration
00:10:00
Advocating for Wealth Equality: Insights from Djaffar Shalchi of Human Act Foundation | Djaffar Shalchi - Founder, Human Act Foundation & Millionaires for Humanity
00:10:00
Azure Minerals: Advanced Zinc-Lead-Silver Project in Sonora
00:10:00
Family Zone, an ASX-listed technology company, is a rising leader in the global cyber safety industry, dedicated to supporting safer online environments.
00:10:00
Newrange Gold Corp: Unveiling High-Grade Gold Potential in Nevada
00:10:00
"Marc Fiorentino, co-founder of Meilleurtaux Placement, hosts Jean-Michel Karam, founder of Memscap, for a presentation on this small-cap stock."|Jean-Michel Karam, founder of Memscap